Updated PECARN Rule Shows High Sensitivity in Predicting Invasive Bacterial Infections in Young Febrile Infants: JAMA
Written By : Medha Baranwal
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-12-17 15:15 GMT | Update On 2025-12-17 15:16 GMT
Advertisement
Canada: A large international study of febrile infants aged 28 days or younger presenting to emergency departments has found that the updated PECARN prediction rule has high sensitivity and clinically acceptable specificity for ruling out invasive bacterial infections or bacterial meningitis.
Published in JAMA, the pooled investigation—led by Brett Burstein from the Montreal Children’s Hospital and McGill University—brings new clarity to a long-standing clinical dilemma. Fever in the first month of life is one of the earliest and often the only signs of severe bacterial illness, including bacteremia and meningitis. Because of this risk, global guidelines have generally recommended routine lumbar punctures for all febrile neonates to rule out meningitis. However, the burden of invasive testing, especially when most infants do not have serious infection, has prompted interest in more selective, evidence-based approaches.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.